TimesSquare Capital Management LLC Sells 33,427 Shares of Stevanato Group S.p.A. $STVN

TimesSquare Capital Management LLC decreased its position in Stevanato Group S.p.A. (NYSE:STVNFree Report) by 1.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,325,539 shares of the company’s stock after selling 33,427 shares during the quarter. Stevanato Group makes up 1.2% of TimesSquare Capital Management LLC’s portfolio, making the stock its 26th biggest position. TimesSquare Capital Management LLC owned approximately 1.10% of Stevanato Group worth $81,243,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Envestnet Asset Management Inc. increased its stake in shares of Stevanato Group by 16.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company’s stock worth $3,324,000 after acquiring an additional 23,545 shares in the last quarter. Raymond James Financial Inc. grew its holdings in Stevanato Group by 77.4% in the first quarter. Raymond James Financial Inc. now owns 468,475 shares of the company’s stock worth $9,566,000 after purchasing an additional 204,391 shares during the period. LPL Financial LLC increased its stake in shares of Stevanato Group by 35.4% during the first quarter. LPL Financial LLC now owns 116,060 shares of the company’s stock valued at $2,250,000 after purchasing an additional 30,339 shares in the last quarter. Bar Harbor Wealth Management purchased a new position in shares of Stevanato Group during the second quarter valued at approximately $9,081,000. Finally, Mutual of America Capital Management LLC lifted its holdings in shares of Stevanato Group by 6.5% during the second quarter. Mutual of America Capital Management LLC now owns 707,123 shares of the company’s stock valued at $17,275,000 after purchasing an additional 43,389 shares during the last quarter.

Analyst Upgrades and Downgrades

STVN has been the subject of a number of analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a research report on Wednesday, November 5th. Morgan Stanley increased their target price on Stevanato Group from $24.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Read Our Latest Analysis on STVN

Stevanato Group Stock Performance

Shares of STVN stock opened at €23.82 on Wednesday. The company has a quick ratio of 1.30, a current ratio of 1.89 and a debt-to-equity ratio of 0.26. The company has a 50 day moving average price of €25.43 and a 200-day moving average price of €24.28. Stevanato Group S.p.A. has a 52 week low of €17.49 and a 52 week high of €28.00. The firm has a market capitalization of $7.21 billion, a PE ratio of 41.79, a P/E/G ratio of 2.39 and a beta of 0.56.

Stevanato Group Company Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Recommended Stories

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVNFree Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.